Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Assistance Publique -Hopitaux De Paris
París, FranciaPublikationen in Zusammenarbeit mit Forschern von Assistance Publique -Hopitaux De Paris (21)
2024
-
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a consortium of prospective cohort studies
The Lancet HIV, Vol. 11, Núm. 2, pp. e106-e116
-
Considering nutritional status to improve outcomes of patients treated by atezolizumab–bevacizumab for advanced hepatocellular carcinoma
Liver International
2023
-
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422
-
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 3, pp. 921-928
-
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106
-
Impact of body mass index on the difficulty and outcomes of laparoscopic left lateral sectionectomy
European Journal of Surgical Oncology, Vol. 49, Núm. 8, pp. 1466-1473
-
Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma
HPB, Vol. 25, Núm. 11, pp. 1302-1322
-
The value of the CHAP model for prediction of the bleeding risk in patients with unprovoked venous thromboembolism: Findings from the RIETE registry
Thrombosis Research
2022
-
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
Gut, Vol. 71, Núm. 9, pp. 1856-1866
-
Minimally Invasive Donor Hepatectomy for Adult Living Donor Liver Transplantation An International, Multi-institutional Evaluation of Safety, Efficacy and Early Outcomes
Annals of Surgery, Vol. 275, Núm. 1, pp. 166-174
-
What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association
JHEP Reports, Vol. 4, Núm. 12
2021
-
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial
Journal of the National Cancer Institute, Vol. 113, Núm. 7, pp. 917-923
-
Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis
Hepatology International, Vol. 15, Núm. 4, pp. 1006-1017
2019
-
Current and innovative emerging therapies for porphyrias with hepatic involvement
Journal of Hepatology, Vol. 71, Núm. 2, pp. 422-433
2017
-
A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases
Hepatology, Vol. 66, Núm. 5, pp. 1644-1661
-
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study
International Journal of Gynecological Cancer, Vol. 27, Núm. 1, pp. 50-58
2015
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
2013
-
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer
Journal of Thrombosis and Haemostasis, Vol. 11, Núm. 1, pp. 71-80
-
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Journal of Thrombosis and Haemostasis, Vol. 11, Núm. 1, pp. 56-70
2012
-
Response assessment in recurrent glioblastoma treated with irinotecan-bevacizumab: Comparative analysis of the Macdonald, RECIST, RANO, and RECIST F criteria
Neuro-Oncology, Vol. 14, Núm. 5, pp. 667-673